VRDN Viridian Therapeutics, Inc.

NASDAQ
$24.29

Viridian Therapeutics, Inc. (VRDN) Institutional Ownership

What the institutions did with VRDN last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.

Managers reporting
265
filed a 13F this quarter
Managers holding
210
-11 on the quarter
Buyers
139
44 opened new
Sellers
105
55 sold out entirely
Buyer share
57.0%
of managers who traded it
Breadth
+13.9
net buyers, as a share of those trading

Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.

Sign in or subscribe

Largest holders

Manager Shares % of reported
FMR LLC 16.6M 12.2%
BlackRock, Inc. 8.6M 6.3%
Bellevue Group AG 6.7M 5.0%
Paradigm Biocapital Advisors LP 6.7M 4.9%
Kynam Capital Management, LP 6.5M 4.7%
STATE STREET CORP 6.1M 4.5%
PRICE T ROWE ASSOCIATES INC /MD/ 5.7M 4.2%
Fairmount Funds Management LLC 5.1M 3.7%
VANGUARD CAPITAL MANAGEMENT LLC 4.6M 3.4%
Deep Track Capital, LP 3.6M 2.6%
Venrock Adviser, LLC 3.3M 2.4%
WELLINGTON MANAGEMENT GROUP LLP 3.1M 2.3%
VANGUARD PORTFOLIO MANAGEMENT LLC 2.8M 2.0%
GEODE CAPITAL MANAGEMENT, LLC 2.5M 1.8%
Avoro Capital Advisors LLC 2.5M 1.8%
BAKER BROS. ADVISORS LP 2.4M 1.8%
Point72 Asset Management, L.P. 2.3M 1.7%
Caligan Partners LP 2.2M 1.6%
NOVO HOLDINGS A/S 2.1M 1.6%
TANG CAPITAL MANAGEMENT LLC 1.8M 1.3%
Fisher Asset Management, LLC 1.8M 1.3%
Candriam S.C.A. 1.7M 1.3%
GOLDMAN SACHS GROUP INC 1.7M 1.2%
First Turn Management, LLC 1.7M 1.2%
DIMENSIONAL FUND ADVISORS LP 1.6M 1.2%

Largest changes

Manager Action Previous Current Change
Kynam Capital Management, LP Increased 2.3M 6.5M +4.1M
Paradigm Biocapital Advisors LP Increased 3.1M 6.7M +3.6M
PRICE T ROWE ASSOCIATES INC /MD/ Increased 3.2M 5.7M +2.5M
CITADEL ADVISORS LLC Reduced 2.3M 41.3K -2.3M
Deep Track Capital, LP Increased 1.4M 3.6M +2.2M
Caligan Partners LP New 0 2.2M +2.2M
Point72 Asset Management, L.P. Increased 322.8K 2.3M +2.0M
STATE STREET CORP Increased 4.7M 6.1M +1.5M
FMR LLC Increased 15.4M 16.6M +1.2M
Fairmount Funds Management LLC Increased 3.9M 5.1M +1.2M
UBS Group AG Increased 307.1K 1.4M +1.1M
VANGUARD PORTFOLIO MANAGEMENT LLC Increased 1.6M 2.8M +1.1M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP Increased 23.3K 1.1M +1.1M
DIMENSIONAL FUND ADVISORS LP Increased 529.8K 1.6M +1.1M
Balyasny Asset Management L.P. Reduced 2.3M 1.3M -1.0M
Avoro Capital Advisors LLC Increased 1.5M 2.5M +1.0M
Candriam S.C.A. Increased 711.7K 1.7M +996.0K
ADAGE CAPITAL PARTNERS GP, L.L.C. Sold Out 970.0K 0 -970.0K
LOOMIS SAYLES & CO L P Sold Out 927.7K 0 -927.7K
Parkman Healthcare Partners LLC Increased 557.9K 1.4M +819.6K
Schonfeld Strategic Advisors LLC New 0 793.5K +793.5K
First Turn Management, LLC Increased 911.3K 1.7M +758.7K
BNP PARIBAS FINANCIAL MARKETS Increased 266.4K 1.0M +745.7K
BlackRock, Inc. Increased 7.8M 8.6M +720.0K
MetLife Investment Management, LLC Reduced 708.5K 52.7K -655.8K

13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.